MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 140 filers reported holding MERSANA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $119,267 | -6.1% | 16,704 | +0.2% | 0.00% | – |
Q3 2022 | $127,000 | +47.7% | 16,669 | -0.4% | 0.00% | – |
Q2 2022 | $86,000 | -98.2% | 16,737 | -98.6% | 0.00% | -100.0% |
Q1 2022 | $4,665,000 | +427.1% | 1,157,635 | +2004.4% | 0.00% | +100.0% |
Q1 2021 | $885,000 | +486.1% | 55,011 | +567.4% | 0.00% | – |
Q4 2020 | $151,000 | +228.3% | 8,243 | +233.6% | 0.00% | – |
Q3 2020 | $46,000 | -97.8% | 2,471 | -97.4% | 0.00% | -100.0% |
Q2 2020 | $2,116,000 | +8038.5% | 93,663 | +1953.6% | 0.00% | – |
Q4 2019 | $26,000 | +420.0% | 4,561 | +43.5% | 0.00% | – |
Q3 2019 | $5,000 | -58.3% | 3,179 | +5.3% | 0.00% | – |
Q2 2019 | $12,000 | +1100.0% | 3,019 | +1605.6% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 177 | +103.4% | 0.00% | – |
Q3 2018 | $1,000 | -80.0% | 87 | -69.3% | 0.00% | – |
Q2 2018 | $5,000 | +66.7% | 283 | +45.1% | 0.00% | – |
Q1 2018 | $3,000 | – | 195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |